Search for: "Wockhardt Limited"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
25 Sep 2013, 12:12 pm
Indianapolis, Indiana -- Alcon Research, Ltd. of Fort Worth, Texas, and Alcon Pharmaceuticals Ltd. of Fribourg, Switzerland (collectively, "Alcon") have filed a patent infringement lawsuit in the Southern District of Indiana alleging that Wockhardt Limited of Mumbai, Maharashta, India; Wockhardt Bio AG of Zug, Switzerland; Wockhardt Bio Ltd. of Zug, Switzerland; and Wockhardt USA, LLC of Parsippany, New Jersey (collectively, "Wockhardt")… [read post]
18 Nov 2008, 10:40 pm
In November 2008, Orion also sued Wockhardt for alleged patent infringement for Stalevo OB listed patents. [read post]
28 Apr 2009, 9:38 pm
FoxNews reports on the settlement of a Hatch-Waxman case between Orion and Wockhardt:Orion Corporation ("Orion") and Wockhardt USA, LLC and Wockhardt Limited (together "Wockhardt") today [April 29] announce that they have executed a settlement agreement on lawsuits filed by Orion in the United States against Wockhardt regarding Wockhardt's submission of abbreviated new drug applications ("ANDAs") for generic… [read post]
3 May 2011, 9:02 am
Wockhardt Limited et al., case number 1:08-cv-1547-TWP-TAB in the Southern District of Indiana before Judge Tanya Walton Prattand Magistrate Judge Tim A. [read post]
14 May 2019, 11:12 am
We affirm thePTAB’s Final Written Decision in Wockhardt. [read post]
28 Apr 2011, 1:40 pm
The court order in SD Ind requires that the remaining defendants not make generic Cymbalta during the patent term and that they tell the FDA that they are no longer seeking approval for a generic duloxetine product during the patent term. [read post]
28 Mar 2014, 5:33 pm
Id. at *8-9 (citations and internal quotation marks omitted).Disclosure of Limited Test Results Does Not Limit Claimed Compound"The plain language of the claim does not include the narrowing limitation that the Appellants desire. [read post]
14 Jul 2021, 11:19 am
Zydus and Wockhardt also have plans to produce vaccines. [read post]
7 Sep 2011, 4:22 am
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
11 May 2011, 4:54 am
General UNCTAD: Bundle of opportunities to improve medicines access in LDCs (IP Watch) Australia: Why IP professionals must take ‘gene patent’ opponents seriously (Patentology) Australia: FCA finds fatal flaw in Plant Breeders Rights Act: Elders Rural Services Australia Limited v Registrar of Plant Breeder’s Rights (Patentology) (ipwars) Finland: Decision on parallel import of pharmaceuticals (Class 46) Italy: Again on MA filing as a preparatory act of marketing –… [read post]
20 May 2009, 5:18 am
’ (Patent Docs) Atripla/Truvada (Efavirenz, Emtricitabine, Tenofovir) – US: Gilead Sciences files second patent infringement lawsuit against Teva Pharmaceuticals over Emtricitabine, a component of Truvada and Atripla (SmartBrief) (The IP Factor) (GenericsWeb) Champix (Varenicline) – India: Pfizer responds to Dr Reddy’s post-grant opposition to Champix filed at Mumbai Patent Office (GenericsWeb) (Spicy IP) Corpril (Ramipril) – Hungary: Metropolitan… [read post]
17 Apr 2010, 7:56 am
One particularly creative (but unsuccessful) attempt to avoid liability was the argument by Wockhardt EU that the early termination of foreign exchange transaction contracts by BNP Paribas, following an event of default, amounted to a penalty in law. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
